In part one of this two-part series, Dr. Jeff Ratliff and Dr. Ron Postuma discuss how frequently the IGLON5 antibody is identified among patients with idiopathic REM behavior disorder.

Show reference:

https://www.neurology.org/doi/10.1212/NXI.0000000000200311